Kelsey E. Koch

AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer

R. Weigel, Anna C. Beck, Tiandao Li, 2021, Molecular Cancer Research.

AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells

R. Weigel, N. Borcherding, T. Williams, 2020, Stem cell reports.

AP-2γ is Required for Maintenance of Pluripotent Mammary Stem Cells

R. Weigel, N. Borcherding, T. Williams, 2020, bioRxiv.

AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis

R. Weigel, Anna C. Beck, Dakota T. Thompson, 2021, Cancer Research.

AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis

R. Weigel, Anna C. Beck, Dakota T. Thompson, 2021 .

A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer

R. Weigel, T. Braun, V. Band, 2019, Molecular Cancer Research.